CTXRCitius Pharmaceuticals, Inc.
0.6002USD-5.85%Mkt Cap: 16.48M $P/E: —3d ago
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment o…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap16.48M $
Enterprise Value24.50M $
Revenue (TTM)5.61M $
Gross Profit4.49M $
Net Income (TTM)-37.43M $
Revenue/Share0.3110 USD
Last Price0.6002 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees23
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.42
PEG—
EV/EBITDA-0.46
EV/Revenue4.37
P/S2.93
P/B0.16
EPS (TTM)-1.64
EPS (Forward)-1.44
52W Range
0.46918% of range2.190
52W High2.190 USD
52W Low0.4691 USD
Profitability
Gross Margin80.07%
Oper. Margin-1827.78%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-55.42%
ROA-28.59%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-26.55M $
CapEx (TTM)—
FCF Margin-596.27%
FCF Yield-203.07%
Net Debt-3.78M $
Net Debt/EBITDA0.07
Balance Sheet
Debt/Equity0.03
Current Ratio0.58
Quick Ratio0.10
Book Value/Sh3.739 USD
Cash/Share0.1670 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 9, 2017
Splits
Last Split1:25
Split DateNov 26, 2024
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)4.000 USD
Upside (mean)+566.4%
Target Range4.000 USD – 4.000 USD
# Analysts1
Ownership
Shares Out.27.45M
Float26.96M
Insiders1.80%
Institutions4.96%
Short Interest
Short Ratio12.3d
Short % Float19.13%
Short % Out.18.79%
Shares Short5.16M
Short (prev mo.)4.76M
Technical
SMA 500.5853 (+2.6%)
SMA 2000.7939 (-24.4%)
Beta0.99
S&P 52W Chg18.16%
Avg Vol (30d)753.80K
Avg Vol (10d)861.28K
Technical Indicators
RSI (14)47.9
MACD0.0228
MACD Signal0.0296
MACD Hist.-0.0068
BB Upper0.8064 USD
BB Middle0.6306 USD
BB Lower0.4548 USD
BB Width55.76%
ATR (14)0.0779 USD
Vol Ratio (20d)0.17x